Critical Therapeutics (Nasdaq: CRTX) 46% HIGHER; Announced that the FDA has approved Dey, L.P.'s New Drug Application for Perforomist Inhalation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE